corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

What's New on our website?

This page lists the most recent additions to our website including Announcements, recent issues of our International News and AdWatch and:
> Publications by Healthy Skepticism Members
> Publications mentioning Healthy Skepticism
> Publications from around the world relevant to drug promotion

Announcements

No Free Lunch is merging with Healthy Skepticism

Conference program: Pharma Knows Best? Managing Medical Knowledge

Prescrire’s proposals for France’s national conference on medicines policy

more

Healthy Skepticism Soapbox

: Open letter to Brown University re journal article misrepresenting efficacy and safety of paroxetine

April 2011: Dispute re Ghostwriting

February 2010: Mother Guilty of Murder—Pediatric Bipolar Disorder Innocent

more

AdWatch

April 2010, USA: Wyeth’s Pristiq® (desvenlafaxine) for major depressive disorder

October 2009, USA: Amylin and Eli Lilly’s Byetta® (exenatide injection) for type 2 diabetes

September 2009, Italy: Lescol (fluvastatin) from Novartis

more

Publications by Healthy Skepticism Members

Recent publications where at least one of the authors is a Healthy Skepticism member.

HSL19675
Hagan K
Ethical fears over Pfizer deal with pharmacists
The Sydney Morning Herald 2011 Oct 20
http://www.smh.com.au/national/health/ethical-fears-over-pfizer-deal-with-pharmacists-20111019-1m817.html

HSL19068
Lacasse JR, Leo J
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research
BMC Research Notes 2011 Jan 31; 4:27
http://www.biomedcentral.com/1756-0500/4/27/abstract

HSL19262
Ramos J
Spotlight on Industry Ties of Health Advocacy Groups
Health Watch 2011 Jan 17
http://healthwatched.org/

HSL19163
Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K
Medicines information provided by pharmaceutical representatives: a com parative study in Australia and Malaysia.
BMC Public Health 2010 Nov 30; 10:(1):743
http://www.biomedcentral.com/1471-2458/10/743

HSL18773
Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry AI
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
PLoS Med 2010 Oct 19; 7:(10):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000352

More

Publications mentioning Healthy Skepticism

Recent publications mentioning Healthy Skepticism written by non-members.

HSL18774
Henry D
Doctors and Drug Companies: Still Cozy after All These Years
PLoS Med 2010 Nov 2;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000359

HSL18819
Blackwell T
Blackwell on Health: Is Pharma influencing doctors’ prescriptions?
National Post 2010 Nov 1
http://news.nationalpost.com/2010/11/01/pharmas-influence-on-doctor-prescribing/#ixzz14vJh3YHQ

HSL18849
Drummond K
Report: Drug Company Money Affects Doctors' Prescriptions
AOL News 2010 Oct 24
http://www.aolnews.com/surge-desk/article/report-drug-company-cash-affects-doctors-prescriptions/19681712

HSL18756
Study finds doctors not immune to pharmaceutical promotion
YFile 2010 Oct 21
http://www.yorku.ca/yfile/archive/index.asp?Article=15726

HSL18777
A HCP’s response to the PLoS study that pharma marketing increases Rx’s
World of DTC Marketing 2010 Oct 20
http://web.archive.org/web/20101226035147/http://worldofdtcmarketing.com/a-hcps-response-to-the-plos-study-that-pharma-marketing-increases-exs/business-of-the-drug-industry/

More

Publications relevant to drug promotion: published in the last 30 days

See other items below (eg. news articles).

- Scholarly journal articles

3 academic journal articles that were published within the past 30 days have been added to the Healthy Skepticism library. To see more go to 2012 or the library home page or the library search page.

HSL19768
Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1; 344:
http://www.bmj.com/content/344/bmj.e14

HSL19794
Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24; 9: (1):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001163

HSL19765
Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10; 344:
http://www.bmj.com/content/344/bmj.d8219

- Other items

12 other items that were published within the past 30 days have been added to the Healthy Skepticism library. To see more go to 2012 or the library home page or the library search page.

HSL19717
Segatto C
O real risco das novas pílulas
Época 2012 Dec 9
http://revistaepoca.globo.com/Saude-e-bem-estar/noticia/2011/12/o-real-risco-das-novas-pilulas.html

HSL19768
Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1 344:
http://www.bmj.com/content/344/bmj.e14

HSL19849
Imprensa RP
Anvisa não pode mais vetar publicidade de medicamentos, diz Justiça
Portal Imprensa 2012 Feb 3
http://portalimprensa.uol.com.br/cdm/caderno+de+midia/47045/anvisa+nao+pode+mais+vetar+publicidade+de+medicamentos+diz+justica

HSL19821
Cohen D
Deborah Cohen: Roche responds
BMJ Group Blogs 2012 Jan 27
http://blogs.bmj.com/bmj/2012/01/27/deborah-cohen-roche-responds/

HSL19794
Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24 9: (1):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001163

HSL19796
Collins G
Call to axe starter packs
6minutes 2012 Jan 23
http://www.6minutes.com.au/news/latest-news/call-to-axe-starter-packs

HSL19783
Alexander J
Health ministry asks state drug controllers to closely monitor misleading ads on vitamins, creams
Pharmabiz 2012 Jan 18
http://pharmabiz.com/NewsDetails.aspx?aid=67061&sid=1

HSL19817
Laurance J
Implant danger extends to all medical devices
The Independent 2012 Jan 18
http://www.independent.co.uk/life-style/health-and-families/health-news/implant-danger-extends-to-all-medical-devices-6291116.html

HSL19816
Pear R
U.S. to Force Drug Firms to Report Money Paid to Doctors
The New York Times 2012 Jan 16
http://www.nytimes.com/2012/01/17/health/policy/us-to-tell-drug-makers-to-disclose-payments-to-doctors.html?_r=3&pagewanted=all

HSL19772
Dabade G
With 100% FDI in pharma, medicines may soon cost more
The Deccan Herald 2012 Jan 15
http://www.deccanherald.com/content/215612/with-100-fdi-pharma-medicines.html

HSL19763
Khor M
TWN Info Service on Intellectual Property Issues
Third World Network 2012 Jan 14
www.twnside.org.sg

HSL19765
Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10 344:
http://www.bmj.com/content/344/bmj.d8219

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.




...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.